Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FA16Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,410
Award facts
- Contract value 100% obligated
- $19,410.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $19,410.43. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of pharmaceutical products through open competition. The order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare operations. The company maintains an extensive portfolio of federal contract awards with DLA covering diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. Zepbound, a GLP-1 receptor agonist used for weight management, represents the type of specialty medication within the company's federal supply capabilities. As a major for-profit pharmaceutical distributor registered in the System for Award Management, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal medical procurement requirements across multiple therapeutic domains and product categories.
Quick answers
Who was awarded contract SPE2DB26FA16Y?
SPE2DB26FA16Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FA16Y worth?
The government has obligated $19,410 on SPE2DB26FA16Y.
Is contract SPE2DB26FA16Y an order under another contract?
Yes. SPE2DB26FA16Y is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA16Y competed?
The extent of competition for SPE2DB26FA16Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award